Navigation Links
PGD can permit the birth of healthy children to women carrying mitochondrial DNA disease
Date:5/30/2011

Amsterdam, The Netherlands: Pre-implantation genetic diagnosis (PGD) can give women at risk of passing on a mitochondrial DNA disorder to their offspring a good chance of being able to give birth to an unaffected child, a researcher told the annual conference of the European Society of Human Genetics today (Monday). Dr. Debby Hellebrekers, from Maastricht University Medical Centre, Maastricht, The Netherlands, said that the scientists' findings could have a considerable effect on preventing the transmission of mitochondrial diseases.

Mitochondria are cellular organelles involved in the conversion of the energy of food molecules into ATP, the molecule that powers most cellular functions. Disruptions of this energy-producing process, due to a defect in the mitochondrial DNA (mtDNA) or nuclear genes, can cause mitochondrial disorders which represent the most common group of inborn errors of metabolism. The manifestation of mtDNA disorders can be quite varied, but the diseases are almost always serious and, if they do not lead to death, they can result in life-long serious disability for children born with them. Symptoms of mtDNA disorders include loss of muscle co-ordination, visual and hearing problems, poor growth, mental retardation, heart, liver and kidney disease, neurological problems, respiratory disorders and dementia.

Prenatal diagnosis is in general not possible for mtDNA diseases, because the clinical signs cannot be reliably predicted from the mutation load (the relative amount of mutated mtDNA molecules) in chorionic villus sampling, so the team of scientists from The Netherlands, Australia, and the UK decided to look at whether PGD would be a better alternative. "If we could find a minimal level of mtDNA mutation load below which the chance for an embryo of being affected was acceptably low", said Dr. Hellebrekers, "we could offer PGD to women who otherwise had little chance of giving birth to a healthy child."

The researchers studied data on 159 different disease-causing mtDNA mutations derived from 327 unrelated patients or families. They combined data on muscle mutant levels which correlate best with prenatal tissues - of affected individuals and relatives on their mothers' side who were not affected., and were able to predict that a 95% or greater chance of being unaffected was linked to a mtDNA mutant level of 18% or less.

Mitochondria have their own DNA, which is strictly inherited from the mother. Normal and mutant DNA co-exist in most disease-causing mtDNA mutations, and there is a threshold of mutant mtDNA which must be exceeded before clinical symptoms occur. The mtDNA mutation level inherited by the offspring of a female mutation carrier can vary greatly, and even in twin births, it is possible for one baby to receive considerably more of the mutant mtDNA molecules than the other.

"Being able to find the minimal level of mutant mtDNA below which the chances of passing on a disorder is low was therefore very important", said Dr. Hellebrekers. Currently, there are no effective treatments for mtDNA disorders. Although we cannot guarantee that a mutant mtDNA level of 18% or lower will result in the birth of an unaffected child, we think that the chances of having a healthy child are high enough to make using PGD in this instance morally acceptable.

"Our research enables us to give genetic counselling to women at risk with respect to their reproductive choices and to provide them, for the first time, with the opportunity to give birth to a healthy baby. The prevalence of mtDNA disorders is 1 in 5,000, which means that the families of about 146,000 patients in Europe can now have the option of having a healthy child. This is a choice that they do not currently have", she concluded.


'/>"/>

Contact: Mary Rice
mary.rice@riceconseil.eu
European Society of Human Genetics
Source:Eurekalert

Related biology news :

1. Plasticity of hormonal response permits rapid gene expression reprogramming
2. Eminent group of scientists call for moratorium on issuance of mountaintop mining permits
3. New open-source software permits faster desktop computer simulations of molecular motion
4. Parental exposure to BPA during pregnancy associated with decreased birth weight in offspring
5. Researchers discover precisely how thalidomide causes birth defects
6. Major breakthrough in preventing premature birth announced by NIH/WSU
7. Fewer multiple births in states with insurance coverage for infertility
8. Study provides explanation for connection between low birth weight and obesity later in life
9. Compound useful for studying birth defects may also have anti-tumor properties
10. Men attend childbirth classes for partners sake
11. New research helps explain how progesterone prevents preterm birth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)...  EyeLock LLC, a leader of iris-based identity ... biometric solution on the latest Qualcomm® Snapdragon™ 835 ... World Congress 2017 (February 27 – March ... 3, Stand 3E10. The Snapdragon ... platform—a combination of hardware, software and biometrics ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist Medical ... its new chief executive officer (CEO). Freischlag joins the ... John D. McConnell , M.D., who last year announced ... the Medical Center, after leading it since 2008.   ... scope of Wake Forest Baptist,s academic health system, which ...
(Date:2/8/2017)... 8, 2017 About Voice Recognition Biometrics Voice ... it against a stored voiceprint template. Acoustic features ... and tone are compared to distinguish between individual ... as most PCs already have a microphone and ... recognition biometrics are most likely to be deployed ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... 2017 A Europe-wide survey of institutes conducted ... animals in their research treat them with due care. The survey ... analysis of the results indicates that there is a strong commitment ... into practice the principles of the 3Rs (Refine, Reduce, Replace)  ... What are the ...
(Date:2/27/2017)... HAMILTON, Bermuda , Feb. 27, 2017 ... ADXS ) and SELLAS Life Sciences Group ... cancer immunotherapies, today announced that Advaxis has granted ... immunotherapy agent using Advaxis, proprietary Lm -based ... heteroclitic peptide antigen mixture (galinpepimut-S). ...
(Date:2/26/2017)... ... February 26, 2017 , ... Rob Lowe is a well ... This series, called "Informed," focuses on issues that are important to the American public ... change issue, which has been a hot topic around the world for a few ...
(Date:2/24/2017)... ... February 24, 2017 , ... Chef Jodi Abel has returned from ... stops in several cities, she gained a number of delicious recipes and new techniques ... town in South Africa’s Western Cape province. It is internationally renowned for its ...
Breaking Biology Technology: